ID   NGAP_HUMAN              Reviewed;        1139 AA.
AC   Q9UJF2; F8W755; O95174; Q2TB22; Q5TFU9;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   04-MAY-2001, sequence version 2.
DT   18-JUN-2025, entry version 194.
DE   RecName: Full=Ras GTPase-activating protein nGAP;
DE   AltName: Full=RAS protein activator-like 2;
GN   Name=RASAL2; Synonyms=NGAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=9877179; DOI=10.1016/s0014-5793(98)01530-0;
RA   Noto S., Maeda T., Hattori S., Inazawa J., Imamura M., Asaka M.,
RA   Hatakeyama M.;
RT   "A novel human RasGAP-like gene that maps within the prostate cancer
RT   susceptibility locus at chromosome 1q25.";
RL   FEBS Lett. 441:127-131(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-1139 (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-89 AND SER-663, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-620 AND SER-663, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   INTERACTION WITH PEAK1.
RX   PubMed=35687021; DOI=10.1083/jcb.202108027;
RA   Zuidema A., Atherton P., Kreft M., Hoekman L., Bleijerveld O.B.,
RA   Nagaraj N., Chen N., Faessler R., Sonnenberg A.;
RT   "PEAK1 Y635 phosphorylation regulates cell migration through association
RT   with Tensin3 and integrins.";
RL   J. Cell Biol. 221:0-0(2022).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-165 AND ASP-379.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway.
CC   -!- SUBUNIT: Interacts with PEAK1. {ECO:0000269|PubMed:35687021}.
CC   -!- INTERACTION:
CC       Q9UJF2; Q96PC5: MIA2; NbExp=3; IntAct=EBI-359444, EBI-1050253;
CC       Q9UJF2; Q15653: NFKBIB; NbExp=2; IntAct=EBI-359444, EBI-352889;
CC       Q9UJF2; Q13077: TRAF1; NbExp=3; IntAct=EBI-359444, EBI-359224;
CC       Q9UJF2; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-359444, EBI-739895;
CC       Q9UJF2; PRO_0000037548 [Q9WMX2]; Xeno; NbExp=2; IntAct=EBI-359444, EBI-6863741;
CC       Q9UJF2-2; P23508: MCC; NbExp=3; IntAct=EBI-12171247, EBI-307531;
CC       Q9UJF2-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12171247, EBI-16439278;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UJF2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJF2-2; Sequence=VSP_045777, VSP_045778;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI10612.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF047711; AAD04814.1; -; mRNA.
DR   EMBL; AL035702; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160281; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL499617; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC110611; AAI10612.1; ALT_INIT; mRNA.
DR   CCDS; CCDS1321.2; -. [Q9UJF2-2]
DR   CCDS; CCDS1322.1; -. [Q9UJF2-1]
DR   RefSeq; NP_004832.1; NM_004841.5. [Q9UJF2-1]
DR   RefSeq; NP_733793.2; NM_170692.4. [Q9UJF2-2]
DR   AlphaFoldDB; Q9UJF2; -.
DR   SMR; Q9UJF2; -.
DR   BioGRID; 114848; 165.
DR   CORUM; Q9UJF2; -.
DR   DIP; DIP-27570N; -.
DR   FunCoup; Q9UJF2; 1503.
DR   IntAct; Q9UJF2; 45.
DR   MINT; Q9UJF2; -.
DR   STRING; 9606.ENSP00000356621; -.
DR   GlyGen; Q9UJF2; 3 sites, 2 N-linked glycans (2 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UJF2; -.
DR   PhosphoSitePlus; Q9UJF2; -.
DR   BioMuta; RASAL2; -.
DR   DMDM; 13959419; -.
DR   jPOST; Q9UJF2; -.
DR   MassIVE; Q9UJF2; -.
DR   PaxDb; 9606-ENSP00000356621; -.
DR   PeptideAtlas; Q9UJF2; -.
DR   ProteomicsDB; 29892; -.
DR   ProteomicsDB; 84621; -. [Q9UJF2-1]
DR   Pumba; Q9UJF2; -.
DR   Antibodypedia; 20575; 154 antibodies from 30 providers.
DR   DNASU; 9462; -.
DR   Ensembl; ENST00000367649.8; ENSP00000356621.3; ENSG00000075391.18. [Q9UJF2-2]
DR   Ensembl; ENST00000462775.5; ENSP00000420558.1; ENSG00000075391.18. [Q9UJF2-1]
DR   GeneID; 9462; -.
DR   KEGG; hsa:9462; -.
DR   MANE-Select; ENST00000367649.8; ENSP00000356621.3; NM_170692.4; NP_733793.2. [Q9UJF2-2]
DR   UCSC; uc001glq.4; human. [Q9UJF2-1]
DR   AGR; HGNC:9874; -.
DR   CTD; 9462; -.
DR   DisGeNET; 9462; -.
DR   GeneCards; RASAL2; -.
DR   HGNC; HGNC:9874; RASAL2.
DR   HPA; ENSG00000075391; Low tissue specificity.
DR   MalaCards; RASAL2; -.
DR   MIM; 606136; gene.
DR   neXtProt; NX_Q9UJF2; -.
DR   OpenTargets; ENSG00000075391; -.
DR   PharmGKB; PA34235; -.
DR   VEuPathDB; HostDB:ENSG00000075391; -.
DR   eggNOG; KOG3508; Eukaryota.
DR   GeneTree; ENSGT00940000157702; -.
DR   HOGENOM; CLU_001727_1_0_1; -.
DR   InParanoid; Q9UJF2; -.
DR   OMA; HAAQMDH; -.
DR   OrthoDB; 5572587at2759; -.
DR   PAN-GO; Q9UJF2; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9UJF2; -.
DR   TreeFam; TF105303; -.
DR   PathwayCommons; Q9UJF2; -.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-9696264; RND3 GTPase cycle.
DR   Reactome; R-HSA-9696273; RND1 GTPase cycle.
DR   SignaLink; Q9UJF2; -.
DR   BioGRID-ORCS; 9462; 7 hits in 1154 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; RASAL2; human.
DR   GeneWiki; RASAL2; -.
DR   GenomeRNAi; 9462; -.
DR   Pharos; Q9UJF2; Tbio.
DR   PRO; PR:Q9UJF2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9UJF2; protein.
DR   Bgee; ENSG00000075391; Expressed in buccal mucosa cell and 179 other cell types or tissues.
DR   ExpressionAtlas; Q9UJF2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:ProtInc.
DR   GO; GO:0060612; P:adipose tissue development; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:2000257; P:regulation of protein activation cascade; IEA:Ensembl.
DR   GO; GO:0002021; P:response to dietary excess; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd04013; C2_SynGAP_like; 1.
DR   CDD; cd05136; RasGAP_DAB2IP; 1.
DR   FunFam; 1.10.506.10:FF:000001; Ras GTPase-activating protein nGAP isoform 2; 1.
DR   FunFam; 2.60.40.150:FF:000010; Ras GTPase-activating protein nGAP isoform 2; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.10.506.10; GTPase Activation - p120gap, domain 1; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR021887; DAB2P_C.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR039360; Ras_GTPase.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   PANTHER; PTHR10194:SF52; RAS GTPASE-ACTIVATING PROTEIN NGAP; 1.
DR   PANTHER; PTHR10194; RAS GTPASE-ACTIVATING PROTEINS; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF12004; DAB2P_C; 1.
DR   Pfam; PF25321; PH_RASGAP; 1.
DR   Pfam; PF00616; RasGAP; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00323; RasGAP; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; GTPase activation; Phosphoprotein;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..1139
FT                   /note="Ras GTPase-activating protein nGAP"
FT                   /id="PRO_0000056653"
FT   DOMAIN          41..158
FT                   /note="PH"
FT   DOMAIN          149..267
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          343..551
FT                   /note="Ras-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   REGION          1..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          684..704
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          751..782
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          803..869
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          910..953
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1116..1139
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        17..36
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        45..56
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        73..87
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        751..760
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        803..818
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        833..855
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        916..928
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            369
FT                   /note="Arginine finger; crucial for GTP hydrolysis by
FT                   stabilizing the transition state"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         620
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         864
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   VAR_SEQ         1..4
FT                   /note="MQTP -> MELSPSSGGAAEALSWPEMFPALESDSPLPPEDLDAVVPVSGAV
FT                   AGGMLDRILLESVCQQQSWVRVYDVKGPPTHRLSCGQSPYTETTTWERKYCILTDSQLV
FT                   LLNKEKEIPVEGGQEQQTDSTKGRCLRRTVSVPSEGQFPEYPPEGATKL (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045777"
FT   VAR_SEQ         590..596
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045778"
FT   VARIANT         165
FT                   /note="R -> W (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs765646105)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035541"
FT   VARIANT         379
FT                   /note="E -> D (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs1274912659)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035542"
SQ   SEQUENCE   1139 AA;  128558 MW;  4A65C8243E1259A3 CRC64;
     MQTPEVPAER SPRRRSISGT STSEKPNSMD TANTSPFKVP GFFSKRLKGS IKRTKSQSKL
     DRNTSFRLPS LRSTDDRSRG LPKLKESRSH ESLLSPCSTV ECLDLGRGEP VSVKPLHSSI
     LGQDFCFEVT YLSGSKCFSC NSASERDKWM ENLRRTVQPN KDNCRRAENV LRLWIIEAKD
     LAPKKKYFCE LCLDDTLFAR TTSKTKADNI FWGEHFEFFS LPPLHSITVH IYKDVEKKKK
     KDKNNYVGLV NIPTASVTGR QFVEKWYPVS TPTPNKGKTG GPSIRIKSRF QTITILPMEQ
     YKEFAEFVTS NYTMLCSVLE PVISVRNKEE LACALVHILQ STGRAKDFLT DLVMSEVDRC
     GEHDVLIFRE NTIATKSIEE YLKLVGQQYL HDALGEFIKA LYESDENCEV DPSKCSSSEL
     IDHQSNLKMC CELAFCKIIN SYCVFPRELK EVFASWKQQC LNRGKQDISE RLISASLFLR
     FLCPAIMSPS LFNLMQEYPD DRTSRTLTLI AKVIQNLANF AKFGNKEEYM AFMNDFLEHE
     WGGMKRFLLE ISNPDTISNT PGFDGYIDLG RELSVLHSLL WEVVSQLDKG ENSFLQATVA
     KLGPLPRVLA DITKSLTNPT PIQQQLRRFT EHNSSPNVSG SLSSGLQKIF EDPTDSDLHK
     LKSPSQDNTD SYFRGKTLLL VQQASSQSMT YSEKDERESS LPNGRSVSLM DLQDTHAAQV
     EHASVMLDVP IRLTGSQLSI TQVASIKQLR ETQSTPQSAP QVRRPLHPAL NQPGGLQPLS
     FQNPVYHLNN PIPAMPKASI DSSLENLSTA SSRSQSNSED FKLSGPSNSS MEDFTKRSTQ
     SEDFSRRHTV PDRHIPLALP RQNSTGQAQI RKVDQGGLGA RAKAPPSLPH SASLRSTGSM
     SVVSAALVAE PVQNGSRSRQ QSSSSRESPV PKVRAIQRQQ TQQVQSPVDS ATMSPVERTA
     AWVLNNGQYE EDVEETEQNL DEAKHAEKYE QEITKLKERL RVSSRRLEEY ERRLLVQEQQ
     MQKLLLEYKA RLEDSEERLR RQQEEKDSQM KSIISRLMAV EEELKKDHAE MQAVIDAKQK
     IIDAQEKRIV SLDSANTRLM SALTQVKERY SMQVRNGISP TNPTKLSITE NGEFKNSSC
//
